BeOne Medicines AG (ONC)

BeOne Medicines AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,037	2,627	3,172	3,870	4,376	1,382
Short-Term Investments	-	-	-	665.25	2,245	3,269
Cash & Short-Term Investments	4,037	2,627	3,172	4,535	6,621	4,651
Cash Growth	48.74%	-17.16%	-30.06%	-31.50%	42.36%	373.24%
Accounts Receivable	863.28	676.28	358.03	173.17	483.11	60.4
Other Receivables	39.1	32.83	37.86	25.82	17.06	19.27
Receivables	902.38	709.11	395.89	198.98	500.18	79.67
Inventory	531.69	494.99	416.12	282.35	242.63	89.29
Prepaid Expenses	29.33	49.37	88.26	83.09	138.81	57.74
Restricted Cash	52.99	9.31	11.47	0.2	0.33	0.31
Other Current Assets	111.22	101.41	119.88	107.65	111.32	83.01
Total Current Assets	5,664	3,992	4,203	5,207	7,614	4,961
Property, Plant & Equipment	1,768	1,718	1,419	955.91	705.04	448.27
Long-Term Investments	100.65	128.93	89.64	91.78	100.79	49.34
Goodwill	-	-	-	-	0.11	0.11
Other Intangible Assets	63.58	51.1	57.14	40.62	46.68	5
Long-Term Deferred Tax Assets	-	-	-	-	-	65.96
Other Long-Term Assets	35.55	31.56	35.72	83.91	69.03	71.39
Total Assets	7,633	5,921	5,805	6,379	8,536	5,601
Accounts Payable	383.68	405	315.11	294.78	262.4	231.96
Accrued Expenses	866.56	780.48	624.92	480.1	534.33	389.75
Short-Term Debt	768.03	816.95	659.79	314.83	424.74	334.71
Current Portion of Long-Term Debt	45.27	34.58	28.58	14.14	2.82	0.31
Current Portion of Leases	15.73	17.58	21.95	24.04	21.93	13.9
Current Income Taxes Payable	11.22	25.93	22.95	25.19	21.4	20.38
Current Unearned Revenue	52.25	-	-	213.86	187.41	-
Other Current Liabilities	225.69	134.39	136.82	101.59	144.53	84.2
Total Current Liabilities	2,368	2,215	1,810	1,469	1,600	1,075
Long-Term Debt	139.57	166.48	197.62	209.15	202.11	183.64
Long-Term Leases	51.39	44.28	22.25	34.52	43.04	29.42
Long-Term Unearned Revenue	861.86	30.32	34.2	80.2	266.64	49.14
Pension & Post-Retirement Benefits	17.04	16.41	15	7.76	7.81	8.11
Long-Term Deferred Tax Liabilities	47.07	42.01	16.49	16	14.17	10.79
Other Long-Term Liabilities	17.91	74.29	172.27	179.78	269.63	375.22
Total Liabilities	3,503	2,589	2,268	1,996	2,403	1,732
Common Stock	0.14	0.14	0.14	0.14	0.13	0.12
Additional Paid-In Capital	12,617	12,088	11,599	11,541	11,191	7,415
Retained Earnings	-8,386	-8,607	-7,962	-7,080	-5,077	-3,553
Comprehensive Income & Other	-101.26	-148.99	-99.45	-77.42	17.95	6.94
Total Common Equity	4,129	3,332	3,537	4,383	6,133	3,869
Shareholders' Equity	4,129	3,332	3,537	4,383	6,133	3,869
Total Liabilities & Equity	7,633	5,921	5,805	6,379	8,536	5,601
Total Debt	1,020	1,080	930.19	596.68	694.64	561.96
Net Cash (Debt)	3,017	1,548	2,242	3,938	5,926	4,089
Net Cash Growth	81.58%	-30.96%	-43.08%	-33.54%	44.94%	479.63%
Net Cash Per Share	27.10	14.70	21.47	38.19	63.87	48.98
Filing Date Shares Outstanding	110.66	106.72	104.58	104.32	102.68	91.6
Total Common Shares Outstanding	110.62	106.72	104.58	104.32	102.68	91.6
Working Capital	3,296	1,777	2,393	3,739	6,014	3,885
Book Value Per Share	37.33	31.22	33.82	42.02	59.73	42.24
Tangible Book Value	4,066	3,281	3,480	4,343	6,086	3,864
Tangible Book Value Per Share	36.75	30.75	33.28	41.63	59.27	42.18
Land	71.43	65.49	65.49	65.49	65.49	-
Buildings	1,167	607.86	231.66	222.45	144.08	111.53
Machinery	556.9	485.14	392.21	334.59	237.79	175.31
Construction In Progress	129.12	654.02	740.62	293.63	186.84	85.78
Leasehold Improvements	73.75	64.68	60.12	53.79	50.29	37.64

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q